William Henry Mullen
Amministratore Delegato presso Momentum Bioscience Ltd.
Profilo
William Henry Mullen is the founder of Provexis Plc (1999) and Momentum Bioscience Ltd.
(2008), where he holds the title of Chief Executive Officer.
Dr. Mullen is also the founder of NeuroTargets Ltd.
He held the title of Chief Executive Officer at ANGLE Technology Ltd.
and Acolyte Biomedica Ltd.
He was also the Chief Executive Officer at Rowett Research Services Ltd.
from 1996 to 1999.
Additionally, he held the position of Director at NXXI, Inc. and was a Principal at Abbott Laboratories from 1993 to 1996.
Posizioni attive di William Henry Mullen
Società | Posizione | Inizio |
---|---|---|
Momentum Bioscience Ltd.
Momentum Bioscience Ltd. Medical/Nursing ServicesHealth Services Momentum Bioscience Ltd. develops a technology for the detection of infection in blood and other normally sterile body fluids. Its solutions include EMA Sepsis, a detection method for organisms in blood; EMA Total, a detection method for organisms in NSF; EMA Bacteria for the detection of bacteria; and EMA Fungi for the detection of fungi. The company was founded by William Henry Mullen in 2008 and is headquartered in Cardiff, the United Kingdom. | Amministratore Delegato | 27/09/2011 |
Precedenti posizioni note di William Henry Mullen
Società | Posizione | Fine |
---|---|---|
Rowett Research Services Ltd.
Rowett Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Rowett Research Services Ltd. provided biotechnology research services. The company was founded in 1988 and was headquartered in Aberdeen, the United Kingdom. | Presidente | 01/01/1999 |
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/1996 |
PROVEXIS PLC | Fondatore | - |
ANGLE Technology Ltd.
ANGLE Technology Ltd. Miscellaneous Commercial ServicesCommercial Services ANGLE Technology Ltd. provides management consulting and venture capital services. | Presidente | - |
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
PROVEXIS PLC | Health Technology |
Aziende private | 6 |
---|---|
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Health Technology |
ANGLE Technology Ltd.
ANGLE Technology Ltd. Miscellaneous Commercial ServicesCommercial Services ANGLE Technology Ltd. provides management consulting and venture capital services. | Commercial Services |
Acolyte Biomedica Ltd.
Acolyte Biomedica Ltd. Miscellaneous Commercial ServicesCommercial Services Acolyte Biomedica Ltd. develops, manufactures, and markets microbiology and cell enumeration systems for clinical diagnostics and life sciences research. Its products include baclite rapid and rapitect. The company was founded in February 2000 and is headquartered in Salisbury, UK. | Commercial Services |
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Health Technology |
Rowett Research Services Ltd.
Rowett Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Rowett Research Services Ltd. provided biotechnology research services. The company was founded in 1988 and was headquartered in Aberdeen, the United Kingdom. | Commercial Services |
Momentum Bioscience Ltd.
Momentum Bioscience Ltd. Medical/Nursing ServicesHealth Services Momentum Bioscience Ltd. develops a technology for the detection of infection in blood and other normally sterile body fluids. Its solutions include EMA Sepsis, a detection method for organisms in blood; EMA Total, a detection method for organisms in NSF; EMA Bacteria for the detection of bacteria; and EMA Fungi for the detection of fungi. The company was founded by William Henry Mullen in 2008 and is headquartered in Cardiff, the United Kingdom. | Health Services |
- Borsa valori
- Insiders
- William Henry Mullen